+ Larger Font | - Smaller Font
Share


Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Diffusion Pharmaceuticals Inc Announces Closing Of 3 5 Million Offering Priced At The Market is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.
Search RobinsPost News & Noticias


Press Release Diffusion Pharmaceuticals Inc Announces Closing Of 3 5 Million Offering Priced At The Market | RobinsPost News & Noticias

Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva


Proceeds to be used to continue to advance rigorously designed clinical trials of Armata's high purity phage-based therapeutic candidates LOS ANGELES, March 4, 2024 /PRNewswire/ -- Armata ... Read More

Telomir Pharmaceuticals Announces Closing of Initial Public Offering


BALTIMORE, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Telomir Pharmaceuticals, Inc. (Nasdaq ... to affect age reversal, today announced the closing of its initial public offering of 1,000,000 shares ... Read More

Oragenics Announces Closing of Public Offering


--(BUSINESS WIRE)-- Oragenics, Inc ... pharmaceuticals for the treatment of neurological disorders, today announced the closing of its previously announced underwritten public offering of ... Read More

NexImmune Announces Closing of $3.67 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules


The gross proceeds to the Company from the offering were approximately $3.67 million ... Inc. (the “Company”). All statements other than statements of historical fact contained in this press ... Read More

Gaxos.ai Inc. Announces $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules


Roseland, NJ, March 13, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc ... closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds from the ... Read More

ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering


H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to the Company from this offering are expected to be $5 million, before deducting the ... Read More

Gaxos.ai Inc. Announces $3.5 Million Private Placement Priced At-The-Market under Nasdaq Rules


H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds from the offering are expected to be approximately $3.5 million, prior to deducting placement ... Read More

Lexaria Announces Closing of $3.6 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules


H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. The gross proceeds to the Company from the offering were approximately $3.6 million before deducting placement agent ... Read More

ASLAN Pharmaceuticals announces $5 million offering


and SINGAPORE - ASLAN Pharmaceuticals ... has announced a registered direct offering and concurrent private placement of securities intended to raise $5 million in gross proceeds. Read More

ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering


and SINGAPORE, March 12, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals ... closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The gross proceeds to ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus